MedPath

Kinaset Therapeutics, Inc.

Kinaset Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2020-01-01
Employees
11
Market Cap
-
Website
http://www.kinasettx.com

Single and Multiple Ascending Dose Study of KN-002

Phase 1
Completed
Conditions
Asthma COPD
Interventions
First Posted Date
2021-08-16
Last Posted Date
2024-08-07
Lead Sponsor
Kinaset Therapeutics Inc
Target Recruit Count
117
Registration Number
NCT05006521
Locations
🇬🇧

Medicines Evaluation Unit, Manchester, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath